EntryPoint Capital »

Lyell Immunopharma shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $273k 19k 14.05

More positions owned by EntryPoint Capital

Standardaero (SARO)
Howmet Aerospace (HWM)
Benchmark Electronics (BHE)
Capital One Financial (COF)
Hayward Hldgs (HAYW)
Huntington Bancshares Incorporated (HBAN)
Bank of America Corporation (BAC)
RBC Bearings Incorporated (RBC)
Gilead Sciences (GILD)
Avient Corp (AVNT)
Donaldson Company (DCI)
Universal Display Corporation (OLED)
Helios Technologies (HLIO)
HEICO Corporation (HEI)
American Homes 4 Rent Cl A (AMH)

View all positions for EntryPoint Capital

Top funds holding Lyell Immunopharma

Arch Venture Corp
GSK
Vanguard Capital Management
Orland Properties
BlackRock
Almitas Capital
Foresite Capital Management V
Millennium Management
Opaleye Management
venBio Partners
Geode Capital Management
Alphabet
Sc China Holding
Renaissance Technologies
Northern Trust

View all funds holding Lyell Immunopharma